课题基金 / 基金详情

Development of the strategy for the quantitative prediction and avoidance of drug-induced Parkinsonism based on pharmacokinetics and pharmacodynamics

Development of the strategy for the quantitative prediction and avoidance of drug-induced Parkinsonism based on pharmacokinetics and pharmacodynamics
基于药代动力学和药效学定量预测和避免药物性帕金森病的策略的制定
批准号:
11470513
负责人:
SAWADA Yasufumi
金额:
$8.7万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

SAWADA Yasufumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
i) The intensity of catalepsy and in vivo receptor occupancies for domapine D1, D2 and muscarinic acetylcholine receptors were investigated for 25 drugs in mice. The intensity of catalepsy was found to be predictable from these receptor occupancies.ii) The relationship between structure and drug-induced parkinsonism was investigated. The diethylaminomethyl moiety was found to play an important role in the induction of parkinsonism.iii) A case of propiverine-induced parkinsonism was found. The mechanisms underlying the induction of parkinsonism by propiverine was investigated in mice.iv) In vitro experiments were carried out to estimate the affinities of 25 drugs for dopamine D1, D2 and muscarinic acetylcholine receptors, which were indispensable for quantitative prediction of drug-induced parkinsonism.v) Developed was the strategy for the quantitative prediction of drug-induced parkinsonism in humans using the above results of i) and iv).vi) The above(iv) strategy was applied to develop a computer-aided drug information system for rational prescription.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
R.Nasu, H.Matsuo, H.Takanaga, H.Ohtani and Y.Sawada: "Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice."Biopharm.Drug Dispos. 21. 129-138 (2000)
R.Nasu、H.Matsuo、H.Takanaga、H.Ohtani 和 Y.Sawada:“定量预测阿莫沙平、桂利嗪和环磷酰胺诱发的小鼠僵直症。”Biopharm.Drug Dispos。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Ohtani and Y.Sawada: "Development and application of the strategy for the quantitative prediction of drug-induced parkinsonisms"Xenobio.Metabol.Dispos.. 16(1). 27-37 (2001)
H.Ohtani 和 Y.Sawada:“药物诱发帕金森病定量预测策略的开发和应用”Xenobio.Metabol.Dispos.. 16(1)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
松井晶子,那須理佐,松尾浩民,高長ひとみ,澤田康文: "In vivoレセプター結合占有率を用いた薬剤性パーキンソニズムの定量的予測"TDM研究. 16. 115-116 (1999)
Akiko Matsui、Risa Nasu、Hirotami Matsuo、Hitomi Takanaga、Yasufumi Sawada:“利用体内受体结合占用定量预测药物诱发的帕金森病”TDM Research 16. 115-116 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nasu R., Matsuo H., Takanaga H., Ohtani H., and Sawada Y.: "Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice"Biopharmaceutics and Drug Disposition. 21. 129-138 (2000)
Nasu R.、Matsuo H.、Takanaga H.、Ohtani H. 和 Sawada Y.:“阿莫沙平、桂利嗪和环磷酰胺诱发小鼠僵直症的定量预测”生物药剂学和药物处置。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Construction of a risk communication system to encourage the correct use of medicine in remote islands/rural communities
    • 批准号:
      25670069
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      SAWADA Yasufumi
    • 依托单位:
    Development of support system for dosage adjustment to avoid drug-drug interactions caused by fluoropyrimidine anti-cancer drugs
    • 批准号:
      24390038
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.65万
    • 财政年份:
      2012
    • 负责人:
      SAWADA Yasufumi
    • 依托单位:
    Development of system to predict fetal toxicity based on PK/PD evaluation by transplacental transfer and effect of drugs
    • 批准号:
      19390040
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      SAWADA Yasufumi
    • 依托单位:
    DEVELOPMENT OF COMPUTER-AIDED PRESCRIPTION SYSTEM FOR PERSONALIZED PHARMACOTHERAPY BASED ON THE PHAEMACOKINETICS AND PHARMACODYNAMICS
    • 批准号:
      16390043
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.87万
    • 财政年份:
      2004
    • 负责人:
      SAWADA Yasufumi
    • 依托单位:
    海外基金